Medical Affairs Executive Forum, April 2011, Basking Ridge, NJ
Upcoming SlideShare
Loading in...5
×
 

Medical Affairs Executive Forum, April 2011, Basking Ridge, NJ

on

  • 1,629 views

High-Level Strategies for Managing and Executing Practice Issues and Challenges

High-Level Strategies for Managing and Executing Practice Issues and Challenges

Statistics

Views

Total Views
1,629
Views on SlideShare
1,628
Embed Views
1

Actions

Likes
0
Downloads
16
Comments
0

1 Embed 1

http://www.slideshare.net 1

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

    Medical Affairs Executive Forum, April 2011, Basking Ridge, NJ Medical Affairs Executive Forum, April 2011, Basking Ridge, NJ Document Transcript

    • R EGI S T ER B Y Fe b r u a r y 2 5 t h , 2 0 1 1 FOR T HE B E S T S AV I NGS PresentsMEDIC ALA FFA IR S EXECUTIVE FORUM Apr il 14-15, 2011 • Dolce Basking Ridge • Basking Ridge, NJ Hig h-Level St r a te g ies for Ma na g ing a nd Execut ing Pr a ct ice Issues a nd Cha lleng es Hear from Medical Affairs, MSL and related Professionals Representing: • AUXILIUM PHARMACEUTICALS • ELI LILLY • AVANIR PHARMACEUTICALS • INTERMUNE • BAYER HEALTHCARE PHARMACEUTICALS • GENZYME • BOEHRINGER-INGELHEIM • JOHNSON & JOHNSON • BRISTOL-MYERS SQUIBB • OTSUKA AMERICA PHARMACEUTICAL • CENTOCOR ORTHO BIOTECH • RS MEDICAL • CEPHALON • TALECRIS PHARMACEUTICALS • DAIICHI SANKYO • VERTEX PHARMACEUTICALS Fe a t u re d P re s e n t a t io n s A ddre ss in g : • Medical Affairs in Today’s Environment • Effectively Communicating Safety Risk Information • Demonstrating Medical Affairs Value • Future Role of MSD/MSLs • REMS Programs • Publication Planning Update for Medical Affairs • Aligning Medical Affairs and Marketing • Medical Device Issues and Challenges • The Current and Future Role of Registries Plu s! – S t ra te g ic Ou t lo o k Pa n e l Gro u p Di s c u ss in g Wha t Un ive r s a l Cha lle n g e s Lie A he a d MaxiMize your Tri-Located with the 8th Annual MSL Best Practices and NetworkiNg! 13th Investigator Initiated Trials Conferences!Sp o nso rs & Exhibito rs: TO REGI S TER CA LL 866-207-6529 o r v i s i t u s a t w w w.e xlp ha r m a .c o m /m e d a ffa ir s fo r u m
    • Who Should Attend: Pharmaceutical, Biotechnology, Specialty, Medical Device, CRO and Service Providers with responsibilities in: Medical Affairs/Field Medical Affairs Medical Education Medical Science Liaisons Investigator Initiated/Sponsored Trials Medical Directors/Strategy Clinical Research Associates Research & Development Post-Marketing Studies/Phase IV Scientific Affairs Project Management Testimonials from Recent ExL Events: Yes, the event met my expectations Very good information and Great content – well-designed – very good. - Giselle Crosa, Sr. Manager, discussions, - Ylva Sjoquist, Research agenda! - Holli Tirabasso, Medical Education Vertex Pharmaceuticals Manager, Ikaria Manager, Allergan Thorough and entertaining - really Very good in every respect, excellent Very good practical info, engaging, Linda Barr, Senior Director, Clinical presentation, Robert E. Kristofco, Director, - Christine Berger, Manager Scientific Education, Development & Regulatory Affairs,” Accera, Inc. Medical Education Group, Pfizer Celgene Sponsorship & Exhibiting Opportunities Do you want to spread the word about your organization’s solutions and services toBasking Ridge potential clients who will be attending this300 North Maple AveBasking Ridge, NJ 07920 USA event? Take advantage of the opportunity toPhone: 800.953.8033 sponsor, underwrite an educational session,Reservations: 800.953.8033Fax: 908.953.3105 host a networking event, or distributeDolce Basking Ridge combines a retreat-like setting with over 20,000 square feet of IACC approved function space. The promotional items to attendees. ExL Pharmaaward-winning Dolce Basking Ridge is the Tri-state region’s setting of choice for business and pleasure. We are less than will work closely with you to customize aan hour west of Manhattan from Interstate 287, 78 and 80. Newark Liberty Airport is a 30-minute drive, while LaGuardia package that suits all your needs. To learnand JFK Airports are just an hour away. more about these opportunities, pleaseIf you require overnight accommodations, please contact reservations directly at 800.953.8033 to book your room. ExL contact the Steve Decker at 212-400-6234,has reserved a block of rooms at a discounted rate for conference participants. Please mention ExL Pharma and theconference name to take advantage of this discount. You must book your room by Wednesday, March 23, 2011 to be or sdecker@exlpharma.com.eligible for the discounted rate. Please book your room as early as possible as the rooms available at this rate are limited.Shuttle Information: We offer Complimentary shuttle service within a 6 mile radius which would include to Basking RidgeTrain Station.Airport Information: Newark International Airport is approximately 30 minutes away. TO R EGI S TER CA LL 866-207-6529 o r v i s i t u s a t w w w.e xlp h a r m a .c o m /m e d a ffa ir s fo r u m
    • Day One ~ April 14, 20118:00 Continental Breakfast & 2:00 Examining the Role of Medical Affairs in Conference Registration Medical Education • Understanding the key issues • Does Medical Affairs have a role?CONFERENCE COMMENCES • Maintaining scientific objectivity • What potential contributions can MA make Shahin Gharakhanian, MD, DPH, VP, Strategic 9:00 Conference Welcome and Chairperson’s Medical Education & Publications, Dept. of Medical Affairs, Opening Remarks Medicines Development Group (MDG) Global R&D, Vertex Michael O. Montgomery, MD, CPI, Director, Worldwide Pharmaceuticals Medical Affairs Immunology Research, Medical Affairs, Centocor Ortho Biotech Services, LLC 2:45 Effectively Communicating Safety Risk Information9:15 Medical Affairs in Today’s Environment • What is industry’s role? • Roles, activities and functions of a contemporary • Targeting physicians, healthcare advocates and patients medical affairs department in today’s environment • What is the amount of risk considering advent of REMS programs • What traditional roles of commercialization have • Addressing safety risk communications as information is more medical affairs taken over? available to patient networks, proprietary networks, medical • What may still lie ahead? education and payor organizations • Navigating information/resources Jeffrey Spears, Director, Medical Affairs, Talecris BioTherapeutics Rebecca Vermeulen, Senior Director, Global Medical Customer Solutions, Eli Lilly10:00 Demonstrating Medical Affairs Value • Overview of key value drivers and productivity 3:30 Networking and Refreshment Break • Adhering to research while aligning with commercial goals • Increasing reliance on compliance and globalization 4:00 Realizing the Importance of REMS Programs • Changing roles of Role of team members Med Directors/MSLs • Anticipating a proper REMS program • Activities not linked to financial return • Managing HCPs lack of experience and unfamiliarity • Recognize the value to patients in terms of assuring safety Leo Plouffe, Jr., MD CM FACOG, Vice President, Women’s and effectiveness Health Care Medical Affairs, Bayer HealthCare Pharmaceuticals • Legal and Compliance considerations10:45 30-Minute Networking and Refreshment Break Gail Rosen Spahn, PharmD, Senior Director, Medical Affairs, Auxilium Pharmaceuticals11:15 Aligning Medical Affairs and Marketing • The importance of integrating the two areas 4:45 INTERACTIVE ROUNDTABLE DISCUSSIONS • Examples when you can’t collaborate for ethical or Choose your preferred topic and discuss in an compliance reasons intimate, break-out style, setting. • Developing Medical Action Plans • Medical Affairs Value • Marketable vs. Non-Marketable Products • Focusing on REMS Craig S. Conoscenti, MD, FCCP, Medical Affairs, • Role in Medical Education Boehringer Ingelheim Pharmaceuticals • Communicating Safety Risk Information • Aligning Medical Affairs & Marketing12:00 Addressing the Current and Future Role • Current & Future Role of Registries of Registries • Tools & Technologies • Finding answers to unanswered questions • Open Table • Developing evidence-based disease management If you would like to suggest a roundtable discussion • Generating data to support market access topic, please email Program Director, Ethan • Building communities of physicians and patients Denkensohn at edenkensohn@exlpharma.com John Yee, MD, MPH, Vice President, Global Medical Affairs, Genzyme Corporation12:45 Luncheon 5:00 Cocktail Reception Network with 8th MSL Best Practices, and 13th Investigator Initiated Trials Attendees. 5:45 Day One Concludes TO R EGI S TER CA LL 866-207-6529 o r v i s i t u s a t w w w.e xlp h a r m a .c o m /m e d a ffa ir s fo r u m
    • DAY TWO ~ April 15, 2011DAY ONE & ROUNDTABLES RE-CAP8:50 Chairperson’s Recap of Day One • Publications policies Michael O. Montgomery, M.D., C.P.I., Director, Worldwide • Investigator agreements Medical Affairs Immunology Research, Medical Affairs, • Author agreements Centocor Ortho Biotech Services, LLC Mina Patel, PhD, Senior Director, Medical Communications, Cephalon9:00 The Role of the CMO and How it Impacts Medical Affairs 2:15 How MSLs work Successfully with • Increasing medical and scientific credibility Medical Affairs • Providing leadership beyond organizational responsibilities • Managing KOLs • Commitment to patient safety and outcomes • Ad Boards and Speakers Management • Field Support Randall Kaye, MD, Chief Medical Officer, • Biz Development Avanir Pharmaceuticals • Future Roles and Responsibilities for MSLs9:45 Medical Affairs in the 21st Century - Josh Cirulli, PharmD, Medical Science Liasion, Otsuka Responding to Dynamic Industry Trends America Pharmaceutical • The Changing Healthcare Environment - The Future of MSLs and MSDs 3:15 Closing Panel Discussion: Five-Year • US Population and HCP Trends - What They Mean and Strategic Outlook How to Respond • What Universal Challenges Lie Ahead? • Healthcare Reform - Impact on Biotech and Pharma • Importance of Expanding Resources • Personalized Medicine and Pharma’s Response • Global ways of working • Changing and Growing Role & Importance of Medical Affairs • Case examples in the Future Jeffrey S. Humphrey, MD, VP, Oncology Medical Strategy, Alan Cohen, MD, FAAP, FCCP, FAAAAI, FACAAI, Bristol-Myers Squibb (moderator) Senior Vice President, Medical Affairs, InterMune Michael O. Montgomery, M.D., C.P.I., Director, Worldwide Medical Affairs Immunology Research, Medical Affairs, 10:30 Networking and Refreshment Break Centocor Ortho Biotech Services, LLC11:00 Medical Affairs Plan Design and Suku Nagendran, MD, Executive Medical Director, Implementation for Product Support Multi TA Head, Medical Affairs, Daiichi Sankyo • Advocacy Plan • Investigator Initiated Studies 4:00 Chairperson’s Closing • Medical Information Plan Conference Concludes • Phase IV • Publication Planning • Sales Training Campbell Alliance11:45 Medical Device Focus - Challenges, Issues, Opportunities, and Strategies for Success • New Challenges TRI-LOCATED with the 8th Annual • Opportunities MSL Best Practices and 13th Investigator • Critical Issues to Address • Strategies for Success Initiated Trial Conferences • Case examples Dominic J. F. Tong, MD, VP, Medical and Clinical Affairs, Maximize your RS Medical Networking Opportunities12:30 Luncheon with Shared Networking Breaks1:30 Publication Planning Update for and Luncheon! Medical Affairs Stay Connected & Interact with us Online! • Recent changes in the industry • publications plans: past, present and future • institutional policies • Authorship • Lexicon: is this just semantics? • Documentation TO R EGI S TER CA LL 866-207-6529 o r v i s i t u s a t w w w.e xlp h a r m a .c o m /m e d a ffa i r s fo r u m
    • Media Partners PM 36O THE FULL SPECTRUM OF PRODUCT MANAGEMENT FIVE WAYS TO REGISTER Fax: 888-221-6750 Phone: 866-207-6528 Mail: ExL Events, Inc. Online: www.exlpharma.com/medaffairsforum 555 8th Ave., Ste. 310 Email: registration@exlpharma.com New York, NY 10018 Registration Fees for Attending ExL’s Executive Medical Affairs Forum PRICING Register by February 25th to take Advantage of Early-Bird Pricing. Standard Rates begin on February 26th and please note that On-Site rates take effect on April 14th Early-Bird Rates $1795 Standard Rates $1995 On-Site $2195 CEU – Please check with an applicable professional association and/or licensing board that accept Continuing Education hours. Save 25% per person when Registering Four For every three simultaneous registrations from your company you will receive a fourth complimentary registration (must register 4 at one time). Please call 866-207-6528. Save 15% per person when Registering Three Can only send three? You can still save 15% off every registration. To take advantage, please call 866-207-6528. Make checks payable to ExL Events, Inc. and write code P323 on your check. You may also use Visa, MasterCard, Discover or American Express. Payments must be received in full prior to the commencement of the conference. Cancellations: If you need to cancel your registration for an upcoming ExL conference, please note the following policies derived from the Start Date of the event: Four weeks or more: A full refund (minus a $95 processing fee), or a voucher to another ExL event valid for two years from the voucher issue date. One to Four weeks: A 50% refund, or a voucher to another ExL event valid for two years from the voucher issue date. Within the Last Week: A voucher to another ExL event valid for two years from the voucher issue date. To receive a refund or voucher, please fax your request to 888-221-6750. Please Note: Conference registrations may be transferred to other colleagues in the event you are unable to attend. Please notify ExL Pharma, info@exlpharma.com, prior to the event with the name and contact information of the replacement attendee. Please Note: Speakers and agenda are subject to change without notice. In the event of a speaker cancellation, every effort to find a suitable replacement will be made. Please Note: Conference registrations may be transferred to other colleagues in the event you are unable to attend. There will be an administrative charge of $300 to substitute exchange and/or replace attendance badges with a colleague occurring within five business days of any ExL Conference. *The opinions of the speakers and attendees do not necessarily reflect those of the companies they represent or ExL Events, Inc.*
    • To Register: ExL Events, Inc. 866-207-6528 Method of Payment:  Check Credit Card 555 8th Avenue, Suite 310 Make checks payable to ExL Events, Inc. 888-221-6750 New York, NY 10018 Card Type: MasterCard  Visa  Discover Amex registration@exlpharma.com Card Number: Exp. Date: www.exlpharma.com/medaffairsforum Name on Card:  Yes! Register me for the conference: Please contact me: Signature:  I’m interested in marketing opportunities at this event  I wish to receive email updates on ExL Pharma’s upcoming events 555 8th Avenue, Suite 310 New York, NY 10018 Name: Title: Priority Code: P323DM Company: Dept.: Address: City: State: Zip: Email: Telephone: Fax: Questions? Comments? Contact Ethan Denkenohn at edenkensohn@exlpharma.com R E GI S T E R B Y Fe b r u a r y 2 5 t h , 2 0 1 1 F OR T H E B E S T S AV I NGS Presents MEDIC AL A FFA IR S EXECUTIVE FORUM April 14-15, 2011 • Dolce Basking Ridge • Basking Ridge, NJThanks to Our Sponsors: Hear from Medical Affairs, MSL and related Professionals Representing: AUXILIUM PHARMACEUTICALS CEPHALON JOHNSON & JOHNSON AVANIR PHARMACEUTICALS DAIICHI SANKYO OTSUKA AMERICA PHARMACEUTICAL BAYER HEALTHCARE PHARMACEUTICALS ELI LILLY RS MEDICAL BOEHRINGER-INGELHEIM INTERMUNE TALECRIS PHARMACEUTICALS BRISTOL-MYERS SQUIBB GENZYME VERTEX PHARMACEUTICALS CENTOCOR ORTHO BIOTECH TO REGI S TER CA LL 866-207-6529 o r v i s i t u s a t w w w.e xlp ha r m a .c o m /m e d a ffa ir s fo r u m